07 Oct INDIGO project starts Phase 1 trial
The INDIGO project, coordinated by AIGHD, has begun its phase 1 trial of a novel low-dose influenza vaccine that combines 1/5th of a dose of a licensed influenza vaccine with a new adjuvant, an ingredient used in several vaccines to help create a stronger immune...